Brexit and Community Pharmacy

Brexit and Community Pharmacy

The UK left the European Union (EU) on Friday 31st January 2020. The country has now entered a transition period until the end of 2020. The GOV.UK website states that, during the transition period, the current rules on trade, travel, and business for the UK and EU will continue to apply.

Letter to the health and social care industry from Chief Commercial Officer Steve Oldfield

The shared objective of Government and those across the medicine supply chain to safeguard the continued supply of medicines to pharmacies and their patients when the UK exits the EU remains. PSNC will continue to represent the interests of community pharmacies in discussions on this topic as part of the Department of Health and Social Care (DHSC) EU Exit Medicines Supply Industry Collaborative Group. We are also working closely with the other national pharmacy organisations via our Community Pharmacy Brexit Forum.

End of the Transition Period

In preparation for leaving the EU (prior to the start of the Transition Period), DHSC developed a multi-layered approach for protecting the supply of medicines and medical goods. These measures have been revisited for the end of the Transition Period, and adapted where necessary.

Read the August 2020 letter to medicine suppliers here or you can view the summarised information provided in this news story.

Key documents

PSNC Briefing 005/19: Key actions for pharmacy contractors to prepare for a no-deal exit from the EU

PSNC Briefing 023/19: Serious Shortage Protocols – A guide for community pharmacy teams

Patient Leaflet: Information to give patients affected by medicines shortages.

 

Government
updates

Contractor
guidance

Serious
Shortage
Protocols

Communications
work

 Information
for patients

MG_5467-2-49-250x166 resized

Brexit
Forum

 



Latest Contract & IT news

View more Contract & IT news >

Endorsing non-Part VIII EPS items

PSNC and the NHS Business Services Authority (NHSBSA) have been receiving more contractor queries about electronic prescriptions endorsed without the...